Los Angeles Capital Management’s Madrigal Pharmaceuticals MDGL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$545K Sell
1,042
-4,561
-81% -$2.18M ﹤0.01% 848
2025
Q4
$2.4M Buy
5,603
+479
+9% +$245K 0.01% 412
2025
Q3
$2.35M Sell
5,124
-25
-0.5% -$9.33K 0.01% 462
2025
Q2
$1.56M Buy
5,149
+2,553
+98% +$761K 0.01% 505
2025
Q1
$860K Sell
2,596
-156
-6% -$51.3K ﹤0.01% 604
2024
Q4
$849K Buy
+2,752
New +$774K ﹤0.01% 670
2023
Q2
Sell
-1,029
Closed -$249K 1234
2023
Q1
$249K Buy
+1,029
New +$280K ﹤0.01% 1072
2021
Q2
Sell
-6,260
Closed -$732K 1619
2021
Q1
$732K Sell
6,260
-5,202
-45% -$607K ﹤0.01% 1049
2020
Q4
$1.27M Buy
11,462
+125
+1% +$15.3K 0.01% 828
2020
Q3
$1.35M Sell
11,337
-1,660
-13% -$180K 0.01% 702
2020
Q2
$1.47M Buy
12,997
+255
+2% +$25.1K 0.01% 711
2020
Q1
$851K Buy
+12,742
New +$1.06M 0.01% 754
2019
Q3
Sell
-2,053
Closed -$215K 1323
2019
Q2
$215K Buy
+2,053
New +$220K ﹤0.01% 1279

Other funds holding MDGL